Suppr超能文献

基于机器学习的糖尿病预测模型中的心血管并发症:系统评价。

Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review.

机构信息

UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), 56000, Kuala Lumpur, Malaysia.

Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), 56000, Kuala Lumpur, Malaysia.

出版信息

Cardiovasc Diabetol. 2023 Jan 19;22(1):13. doi: 10.1186/s12933-023-01741-7.

Abstract

Prediction model has been the focus of studies since the last century in the diagnosis and prognosis of various diseases. With the advancement in computational technology, machine learning (ML) has become the widely used tool to develop a prediction model. This review is to investigate the current development of prediction model for the risk of cardiovascular disease (CVD) among type 2 diabetes (T2DM) patients using machine learning. A systematic search on Scopus and Web of Science (WoS) was conducted to look for relevant articles based on the research question. The risk of bias (ROB) for all articles were assessed based on the Prediction model Risk of Bias Assessment Tool (PROBAST) statement. Neural network with 76.6% precision, 88.06% sensitivity, and area under the curve (AUC) of 0.91 was found to be the most reliable algorithm in developing prediction model for cardiovascular disease among type 2 diabetes patients. The overall concern of applicability of all included studies is low. While two out of 10 studies were shown to have high ROB, another studies ROB are unknown due to the lack of information. The adherence to reporting standards was conducted based on the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) standard where the overall score is 53.75%. It is highly recommended that future model development should adhere to the PROBAST and TRIPOD assessment to reduce the risk of bias and ensure its applicability in clinical settings. Potential lipid peroxidation marker is also recommended in future cardiovascular disease prediction model to improve overall model applicability.

摘要

预测模型自上世纪以来一直是各种疾病诊断和预后研究的焦点。随着计算技术的进步,机器学习(ML)已成为开发预测模型的广泛使用工具。本综述旨在调查使用机器学习开发 2 型糖尿病(T2DM)患者心血管疾病(CVD)风险预测模型的最新进展。基于研究问题,在 Scopus 和 Web of Science(WoS)上进行了系统搜索以寻找相关文章。根据预测模型风险偏倚评估工具(PROBAST)声明,对所有文章的偏倚风险(ROB)进行评估。发现神经网络的准确率为 76.6%,敏感度为 88.06%,曲线下面积(AUC)为 0.91,是开发 2 型糖尿病患者心血管疾病预测模型最可靠的算法。所有纳入研究的适用性总体关注程度较低。虽然有 2 项研究的 ROB 较高,但由于缺乏信息,另外一些研究的 ROB 未知。根据个体预后或诊断的多变量预测模型透明报告(TRIPOD)标准进行报告标准的遵守情况,总分为 53.75%。强烈建议未来的模型开发应遵循 PROBAST 和 TRIPOD 评估,以降低偏倚风险,并确保其在临床环境中的适用性。还建议在未来的心血管疾病预测模型中使用潜在的脂质过氧化标志物,以提高整体模型适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecce/9854013/c71197856a0d/12933_2023_1741_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验